European Journal of Translational Myology (Mar 2016)

Effect of cellular therapy in progression of Becker’s muscular dystrophy: a case study

  • Alok Sharma,
  • Hemangi Sane,
  • Nandini Gokulchandra,
  • Rishabh Sharan,
  • Amruta Paranjape,
  • Pooja Kulkarni,
  • Jayanti Yadav,
  • Prerna Badhe

DOI
https://doi.org/10.4081/ejtm.2016.5522
Journal volume & issue
Vol. 26, no. 1

Abstract

Read online

Becker muscular dystrophy (BMD) is an inherited disorder due to deletions of the dystrophin gene that leads to muscle weakness. Effects of bone marrow mononuclear cell (BMMNC) transplantation in Muscular Dystrophy have shown to be safe and beneficial. We treated a 20-year-old male suffering from BMD with autologous BMMNC transplantation followed by multidisciplinary rehabilitation. He presented with muscle weakness and had difficulty in performing his activities. The BMMNCs were transplanted via intrathecal and intramuscular routes. The effects were measured on clinical and functional changes. Over 9 months, gradual improvement was noticed in muscle strength, respiratory functions and North Star Ambulatory Assessment Scale. Functional Independence Measure, Berg Balance Score, Brooke and Vignos Scale remained stable indicating halting of the progression. The case report suggests that cellular therapy combined with rehabilitation may have possibility of repairing and regenerating muscle fibers and decreasing the rate of progression of BMD.

Keywords